The Next Phase: Exploring Innovation in Clinical Trials

Lauren Stockwell, Director of Outreach and Engagement for Clinical Research Fastrack, works to bridge gaps in the clinical research workforce. She discusses the emergence of non-traditional candidates and how their unique skills can rejuvenate the field. Lauren highlights the importance of diversity and mentorship in fostering an inclusive environment. The Clinical Research Fastrack program aims to equip future researchers with essential skills, emphasizing networking opportunities and the potential for positive medical advancements.

Julia Sundari, Senior Director of Clinical Design and Analytics at IQVIA, brings three decades of experience in clinical research, starting with a NASA trial. She discusses innovative strategies transforming clinical trials, such as remote monitoring and decentralized approaches. Julia emphasizes the need for diversity in trial participation and the potential of AI and machine learning to enhance design and execution. She also explores how technology can streamline coordination through single data entry systems, all while prioritizing user-centered design for better patient experiences.

Building better protocols — As we think about DCTs, site capabilities, diversity, equity & inclusion, and going global in research, it comes down to how protocol is designed and then ultimately, how regulatory agencies are going to view and deliver on these promises. Our latest guest Douglas Reichgott, Executive Director of Clinical Research at Beth Israel Deaconess Medical Center, shares his insights on the industry, reflecting on the changes he’s witnessed over the past 25 years and sharing his desires for the future in clinical research. Join us as we discuss;Benefits and challenges of DCTsThe future of technology integration: streamlining systems and data Empathy in research and the importance of putting people first Soft skills for success in the field

The ultimate goal in the Clinical Research space is to make trials more accessible to the broader population. Inevitably, the industry has been struggling with enrollment and recruitment. In this episode, our guest Darcy Forman, Chief Delivery Officer at Science 37, shares insight into the implications of increasing clinical research accessibility, from increasing awareness among the general population to testing medications within the populations that will ultimately benefit from the treatments.Join us as we discuss:Pros and cons of transitioning from the pharmaceutical industry to the tech vendor/business side Pressing challenges of enrollment and recruitment in clinical trialsHurdles to providing global scalable execution

Clinical research is moving faster than ever. With developments in technology, distributed trials and accelerated research opportunities, the way we treat patients is adapting.According to Lauren Chang, VP of Strategic Growth at Clinical Research Fastrack, working in the evolving, accelerated world of clinical research takes a particular skillset — something she’s dedicated herself to helping cultivate in her current role. Join us as we discuss:The value of tech skills in any clinical practiceDeveloping professional relationships and seeking mentorshipHard and soft skills necessary for entering clinical research

The focus on diversity, equity and inclusion (DEI) is gaining momentum across pharma and clinical trial environments. But, often, initiatives are difficult to enact within existing industry infrastructures. To truly embrace DEI in clinical trials, clinical trials must enter community clinics — many of which are not quite ready to enter the trials space.While the challenge is no small feat, our latest guest Jennifer Kim, Assistant Professor at Tufts University School of Dental Medicine is out to change the world of pharma and clinical trials by increasing access and diversity. According to her, DEI efforts take more than patient diversity — they require attention to how we design research, drug development, team dynamics and much more.Join us as we discuss;Readying community clinics for clinical trials to expand research and engagementCombatting community misconceptions and embracing DCT opportunities The role of regulatory agencies in driving change

Suzanne Kincaid, Chief Operating Officer at Aperio Clinical Outcomes, discusses her journey from participating in a clinical trial to leading innovations in biotechnology research. She highlights how high-tech solutions improve workflow and early detection in trials. Kincaid emphasizes the role of decentralized trials in enhancing diversity and accessibility for participants. She shares insights on the importance of networking and mentorship in advancing careers within clinical research, showcasing the promising future of enhanced collaboration and efficiency in the field.

Join Susan Mauermann, a start-up specialist focused on innovative clinical trial solutions, and Jennifer Brown, a research operations expert with over two decades of experience. They dive into the exciting role technology plays in making clinical trials more accessible. The conversation covers trends and operational hurdles, the importance of decentralized trials, and how community involvement enhances participation. They also discuss how to overcome self-imposed burdens and the need for standardized data collection to improve patient experiences.

In this discussion, Tyler Payne, Director of Conduct Enablement at CVS Health, shares his journey through the healthcare industry, including time at a phase one clinic and startup. He emphasizes the pivotal role of technology in revolutionizing clinical trials, especially through decentralized approaches. Tyler highlights the challenges posed by COVID-19 and the importance of collaboration among stakeholders to enhance trial experiences. He also offers valuable advice for newcomers aiming to break into the field, emphasizing mentorship and building connections.

Join Kimberly Jenkins, Research Administrator at Cleveland Clinic with 20 years of experience in clinical research, as she discusses the exciting trends reshaping patient care. She highlights the importance of technology and data analytics in evolving clinical trials, while emphasizing the need for diversity and inclusion in the industry. Jenkins also addresses the crucial balance between technological advancements and maintaining human connections in healthcare. Her insights provide a compelling glimpse into the future of clinical research.